RxDoctor Payments Data

Roxanne Klenk, NP

Adult Health · Linwood, MINPI 1891192654

Payments from drug & device makers

$1,691in general payments, 2019–2025

Across 85 payments — averaging $19.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vanda Pharmaceuticals Inc.$244
  • AbbVie$178
  • Axsome Therapeutics, Inc.$132
  • Corcept Therapeutics$106
  • GSK$105
  • Lilly USA, LLC$91
  • plus $836 from 22 others

What the payments were for

  • Food & beverage$1,691100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,691 in reported general payments places this provider in the 75th percentile of 527 adult health providers in Michigan.

See all adult health providers in Michigan

Medicare billing

Part B allowed, 2024
$17,619
Medicare patients
88
Services billed
227

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban51$56,528
OzempicSemaglutide26$29,980
JanuviaSitagliptin Phosphate28$28,527
Trelegy ElliptaFluticasone/Umeclidin/Vilanter36$22,604
Atrovent HfaIpratropium Bromide23$18,755
TrulicityDulaglutide14$15,544
LinzessLinaclotide16$12,135
Spiriva RespimatTiotropium Bromide17$11,419
EntrestoSacubitril/Valsartan11$10,957
JardianceEmpagliflozin16$10,740
SymbicortBudesonide/Formoterol Fumarate34$9,926
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate21$8,133
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen443$7,883
BrilintaTicagrelor15$6,999
TrintellixVortioxetine Hydrobromide12$6,687

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$21$56,52851 claims
Novo NordiskOzempic, Novolog$60$31,02741 claims
GSKTrelegy Ellipta$105$22,60436 claims
AstraZenecaSymbicort, Brilinta$20$16,92549 claims
Lilly USA, LLCTrulicity$91$15,54414 claims
AbbVieLinzess$178$12,13516 claims
NovartisEntresto$50$10,95711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 527 adult health providers in Michigan.

Other adult health in Linwood

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →